166 related articles for article (PubMed ID: 11533917)
1. Innovative approaches to the preservation of the peritoneal membrane: from bench to bedside.
Jörres A
Adv Ren Replace Ther; 2001 Jul; 8(3):164-72. PubMed ID: 11533917
[TBL] [Abstract][Full Text] [Related]
2. Continuous flow peritoneal dialysis: solution formulation and biocompatibility.
Passlick-Deetjen J; Lage C; Jörres A
Semin Dial; 2001; 14(5):384-7. PubMed ID: 11679109
[TBL] [Abstract][Full Text] [Related]
3. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
Haag-Weber M
Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
[TBL] [Abstract][Full Text] [Related]
4. Glucose degradation products in peritoneal dialysis: from bench to bedside.
Jörres A
Kidney Blood Press Res; 2003; 26(2):113-7. PubMed ID: 12771536
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal dialysis: from bench to bedside and bedside to bench.
Perl J; Bargman JM
Am J Physiol Renal Physiol; 2016 Nov; 311(5):F999-F1004. PubMed ID: 27009336
[TBL] [Abstract][Full Text] [Related]
6. Recent concepts in the molecular biology of the peritoneal membrane - implications for more biocompatible dialysis solutions.
Mortier S; De Vriese AS; Lameire N
Blood Purif; 2003; 21(1):14-23. PubMed ID: 12566656
[TBL] [Abstract][Full Text] [Related]
7. The peritoneal-renal syndrome.
Nessim SJ; Bargman JM
Nat Rev Nephrol; 2013 May; 9(5):302-6. PubMed ID: 23507827
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal Membrane Preservation.
Bajo MA; Del Peso G; Teitelbaum I
Semin Nephrol; 2017 Jan; 37(1):77-92. PubMed ID: 28153197
[TBL] [Abstract][Full Text] [Related]
9. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal membrane structural and functional changes during peritoneal dialysis.
Goffin E
Semin Dial; 2008; 21(3):258-65. PubMed ID: 18363601
[TBL] [Abstract][Full Text] [Related]
11. How to Improve the Biocompatibility of Peritoneal Dialysis Solutions (without Jeopardizing the Patient's Health).
Bonomini M; Masola V; Procino G; Zammit V; Divino-Filho JC; Arduini A; Gambaro G
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360717
[TBL] [Abstract][Full Text] [Related]
12. Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis.
Haas S; Schmitt CP; Arbeiter K; Bonzel KE; Fischbach M; John U; Pieper AK; Schaub TP; Passlick-Deetjen J; Mehls O; Schaefer F
J Am Soc Nephrol; 2003 Oct; 14(10):2632-8. PubMed ID: 14514742
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products.
Rippe B; Simonsen O; Heimbürger O; Christensson A; Haraldsson B; Stelin G; Weiss L; Nielsen FD; Bro S; Friedberg M; Wieslander A
Kidney Int; 2001 Jan; 59(1):348-57. PubMed ID: 11135090
[TBL] [Abstract][Full Text] [Related]
14. Low GDP Solution and Glucose-Sparing Strategies for Peritoneal Dialysis.
Szeto CC; Johnson DW
Semin Nephrol; 2017 Jan; 37(1):30-42. PubMed ID: 28153193
[TBL] [Abstract][Full Text] [Related]
15. Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions.
Pletinck A; Vanholder R; Veys N; Van Biesen W
Nat Rev Nephrol; 2012 Sep; 8(9):542-50. PubMed ID: 22777203
[TBL] [Abstract][Full Text] [Related]
16. Effect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-Analysis.
Yohanna S; Alkatheeri AM; Brimble SK; McCormick B; Iansavitchous A; Blake PG; Jain AK
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1380-8. PubMed ID: 26048890
[TBL] [Abstract][Full Text] [Related]
17. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
Higuchi C; Nishimura H; Sanaka T
Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
[TBL] [Abstract][Full Text] [Related]
18. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
[TBL] [Abstract][Full Text] [Related]
19. Encapsulating Peritoneal Sclerosis.
Alston H; Fan S; Nakayama M
Semin Nephrol; 2017 Jan; 37(1):93-102. PubMed ID: 28153198
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal defense mechanisms--the effects of new peritoneal dialysis solutions.
Kazancioglu R
Perit Dial Int; 2009 Feb; 29 Suppl 2():S198-201. PubMed ID: 19270217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
